AI-generated summary
The authors prospectively treated 130 papillomatous intradermal nevi in 90 patients using a combined CO2, erbium:YAG and ruby laser approach. They report that 2.3% recurred as a pigmented macule and 6.9% recurred as a papule or nodule, and that 88% of patients were very satisfied. The abstract does not describe a control group.
- Participants
- 90
- Who or what was studied
- Patients aged 13 to 67 years with papillomatous intradermal nevi (90 patients; 130 nevi)
- Limits stated in the abstract
- The abstract describes a single prospective study without a control group and reports no follow-up duration.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.